Efficacy, Immunogenicity and Safety of BBIBP-CorV Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.

Clinical trial NCT04984408 · UNKNOWN

Trial details

NCT number: NCT04984408
Sponsor: International Vaccine Institute
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

COVID-19 Disease

Start date: 2021-10-01
Primary completion: 2024-09-30
Enrollment: 8825

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.